-
-
-
-
-
-
-
Verastem (VSTM) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Verastem Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Verastem (VSTM) Misses Q2 EPS by 7c
-
-
-
-
-
-
-
Verastem (VSTM) Misses Q1 EPS by 5c, Revenues Miss; FY19 Revenue Guidance Below Consensus
-
-
-
-
-
-
-
New Research: Key Drivers of Growth for Q2, BioTime, Verastem, Fair Isaac, Ulta Beauty, and Chimerix — Factors of Influence, Major Initiatives and Sustained Production
-
-
-
-
-
-
-
Hercules Capital Achieves More Than $880 Million in New Commitments in 2017(1)
-
976,748 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All